Title
Category
Credits
Event date
Cost
- SAICEP
- 1.00 Participation
$0.00
Melissa Jim, MPH will describe our IHS linkage and characterize patterns of cancer incidence among AI/AN by IHS Region. We will discuss sources of AI/AN cancer data. I will also explore the United States Cancer Statistics: Data Visualizations website to show how to find AI/AN cancer data by IHS Region. Accurate cancer data is crucial to develop public health strategies and programs to address cancer disparities.
Using Acceptance and Commitment Therapy to Help Cancer Survivors Move Forward After Treatment - SPOC
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Cancer survivors may face many unique psychosocial challenges. Melissa Holt, DNP, PMHNP-BC and Lisa Kanser, PsyD discuss Acceptance and Commitment Therapy (ACT) is an evidence-based psychotherapeutic approach that can effectively teach patients skills to manage these challenges after completing cancer treatment. We will take you through case vignettes to show you how ACT can be applied to this patient population.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Taking a deeper dive into the most common oncologic emergencies facing oncology patients. We will discuss the clinical manifestations, diagnosis, treatment, and prevention of Neutropenic Fever, Tumor Lysis Syndrome, and Cord Compression. These topics are good refreshers for APPs practicing in primary care, urgent, emergency medicine, hematology/oncology, and inpatient medicine.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Nancy Vogler, AGPCNP-BC, will discuss the common types of anemia and thrombocytopenia, common causes of each, how the non-hematology provider can best manage patients with anemia and/or thrombocytopenia, and when to refer to hematology.
- Advanced Practice Provider
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Oral oncolytics have revolutionized cancer care over the last two decades. Although they provide a more convenient & often more tolerable alternative to traditional chemotherapy agents, their unique mechanisms of action lead to a wide range of potential side effects. In this CPP panel discussion, Aimee Faso, Bianka Patel, and Kevin Chen will discuss the considerations when managing side effects for patients receiving oral oncolytic treatments for various solid tumor and hematologic malignancies.
- SAICEP
- 1.00 Participation
$0.00
Cancer touches all of our lives. For many Native communities, fears of cancer risk from environmental sources beyond their control are common. Some researchers, usually unaware of Native community concerns, can harbor the perspective that Native communities could be fruitful populations for studying the genetic risks of cancer. This webinar will help both sides of this chasm understand the other's point of view, hopefully leading to more effective communications and priority setting.
- 1.00 Participation
$0.00
Course DescriptionIn this talk, Kaitlin Morrison, PhD will take you through how to develop and implement a quality management plan to ensure you get good clinical trial results on your investigator-initiated trial (IIT).
- 1.00 Participation
$0.00
Course DescriptionIn this talk, Kaitlin Morrison, PhD will take to you about the 3 major reasons that protocols requirement amendments and how to avoid them.
- Patient Centered Care
- 1.00 Participation
$0.00
Chemotherapy-induced neuropathy is a major clinical problem that can lead to persistent issues for cancer survivors and can even limit the use of planned chemotherapy treatment during the course of care. Cryotherapy is already an established treatment for other chemotherapy induced conditions such as alopecia and mouth mucositis. This course will explore the evidence for using this low-cost intervention to reduce the incidence/severity of chemotherapy-induced neuropathy.
- 1.00 Participation
$0.00
Course DescriptionKaitlin Morrison, PhD takes you through a quick 5 tips that will help you and your team successfully manage an IND.